combined treatment [topp]
Gemfibrosil [lipd, phsu]
Refractory [ftcn]
familial hyperlipemia [dsyn]
Combined [qlco]
Clinical Study [resa]
This [euka]
Study [mnob]
carried [acty]
Out [spco]
Assess [acty]
Efficacy [qlco]
Safety [hcpp]
Combined therapy [topp]
Pravastatin [orch, phsu]
Gemfibrosil [lipd, phsu]
Patients [podg]
Severe [qlco]
Refractory [ftcn]
Familial combined hyperlipidaemia [dsyn]
Patients [podg]
Men [popg]
Women [popg]
Mean [qnco]
Age [orga]
Range [qnco]
included [ftcn]
Study [mnob]
Patients [podg]
secondary [neop]
forms [qlco]
Dyslipoproteinemia [patf]
Excluded [idcn]
Patients [podg]
Following [tmco]
Phase [tmco]
Ii [aapp]
American Heart Association [hcro]
Diet [food]
Plus [qlco]
placebo [topp]
Beginning [tmco]
month [tmco]
Patients [podg]
Received [qlco]
months [tmco]
combined treatment [topp]
Fixed [fndg]
Dosage [qnco]
Gemfibrosil [lipd, phsu]
mg day [qnco]
divided [ftcn]
Equal [qlco]
Doses [qnco]
Pravastatin [orch, phsu]
mg day [qnco]
Dosage [qnco]
Pravastatin [orch, phsu]
Increased [qnco]
mg day [qnco]
months [tmco]
Following [tmco]
Parameters [fndg]
Measured [qlco]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Very low density lipoprotein cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Apoproteins B [aapp, bacs]
I- [inch]
Patients [podg]
free [ftcn]
coronary heart disease [dsyn]
baseline [bodm]
Effect [qlco]
treatment [ftcn]
Risk [qlco]
Myocardial Infarction [dsyn]
Calculated [ftcn]
treatment [ftcn]
Initiation [menp]
Mean [qnco]
Values [qlco]
SD [fndg]
Measured [qlco]
Parameters [fndg]
Total Cholesterol [lbpr]
mg dl [qnco]
Triglycerides [bacs, lipd]
mg dl [qnco]
Low Density Lipoprotein Cholesterol [bacs, strd]
mg dl [qnco]
Very low density lipoprotein cholesterol [bacs, strd]
mg% [qnco]
DI [gngm]
High Density Lipoprotein Cholesterol [bacs, lipd]
mg dl [qnco]
Apoprotein [aapp, bacs]
mg dl [qnco]
Apoprotein(a) [aapp, bacs]
I- [inch]
mg dl [qnco]
months [tmco]
combined treatment [topp]
Following [tmco]
Percentage [qnco]
Record [inpr]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Very low density lipoprotein cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Apoprotein [aapp, bacs]
Apoprotein(a) [aapp, bacs]
Low Density Lipoprotein Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Ratio [qnco]
Apoprotein [aapp, bacs]
I- [inch]
Ratio [qnco]
Relative Risk [qnco]
Myocardial Infarction [dsyn]
Reduced [qlco]
P NOS [aapp, imft]
Withdrawn [fndg]
Expired [orgf]
Study [mnob]
treatment adverse effect [patf]
Induced [ftcn]
Five [qnco]
Patients [podg]
Exhibit [inpr]
Moderate [qlco]
Transient [popg]
Serum [bdsu]
Enzyme [enzy, orch]
Elevation [topp]
Creatinine [bacs, orch]
Kinase [aapp, enzy]
Transaminase [aapp, enzy]
Myopathy [dsyn]
Rhabdomyolysis [patf]
Major [qlco]
Gastrointestinal symptoms NOS [sosy]
Deterioration [phpr]
Renal function [ortf]
Insomnia [sosy]
Not [ftcn]
Record [inpr]
Patients [podg]
combined treatment [topp]
Gemfibrosil [lipd, phsu]
Pravastatin [orch, phsu]
effective [qlco]
Administered [ftcn]
Only [qnco]
Select [acty]
Patients [podg]
Severe [qlco]
Combined hyperlipidemia NOS [dsyn]
